The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - ArQule; Jubilant DraxImage
Research Funding - Agios (Inst); Aileron Therapeutics (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.
 
Ami Vijay Desai
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Merck
Research Funding - Jubilant DraxImage (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Andrew Gilman
Employment - PRA Health Sciences
Consulting or Advisory Role - Partner Therapeutics
 
Mehmet Fevzi Ozkaynak
No Relationships to Disclose
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Wendy B London
No Relationships to Disclose
 
Sheena Cretella Tenney
No Relationships to Disclose
 
Malcolm Smith
No Relationships to Disclose
 
Nita Seibel
No Relationships to Disclose
 
Hiroyuki Shimada
No Relationships to Disclose
 
Katherine K. Matthay
No Relationships to Disclose
 
Susan Lerner Cohn
Stock and Other Ownership Interests - Abbvie; Accelerated Medical Diagnostics; Amgen; Amgen (I); Anthem INC; Cardinal Health; Jazz Pharmaceuticals; Lilly; Merck; Novo Nordisk; Pfizer; Pfizer (I); Regeneron; Sanofi; Stryker; Stryker (I); United Therapeutics; United Therapeutics (I); Varex Imaging; Zimmer BioMet
Research Funding - Merck (Inst); United Therapeutics (Inst)
 
John M. Maris
Consulting or Advisory Role - Auron Therapeutics; Illumina Radiopharmaceuticals
Patents, Royalties, Other Intellectual Property - GPC2 binders and CARs (Inst); Neuroblastoma antigens (Inst)
 
Rochelle Bagatell
No Relationships to Disclose
 
Paul M. Sondel
Patents, Royalties, Other Intellectual Property - I am an unpaid medical advisor to Invenra Inc. a monoclonal antibody biotech firm in Madison WI. My UW lab is collaborating with Invenra and receiving research reagents from them for mutual research. (Inst); I have partial interest in patents related to my work at the University of Wisconsin-Madison WI, that are held by and managed by the University of Wisconsin Foundation
(OPTIONAL) Uncompensated Relationships - Invenra
 
Julie R. Park
No Relationships to Disclose
 
Alice L. Yu
Leadership - OPKO Health
Stock and Other Ownership Interests - OBI Pharma; OPKO Health/GeneDx
Honoraria - EUSA Pharma
Consulting or Advisory Role - OBI Pharma
Speakers' Bureau - EUSA Pharma
Research Funding - United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - cancer targeting peptides; Globo H-Diphtheria toxoid vaccine for cancer therapy; NKT stimulatory phenyl-glycolipids for cancer therapy and vaccine adjuvant
Travel, Accommodations, Expenses - EUSA Pharma